Perion to be Acquired by Affle for $420 Million

Perion (PERI) entered into a merger agreement on November 1, 2026, to be acquired by Affle 3i Ltd. in a deal valued at $420 million.

Deal Structure:

Perion shareholders will receive cash consideration of $11.70 per share, representing a 34.48% premium over the stock’s last close.

Company Profile:

Perion Network is an Israel-based digital advertising technology company that provides advertising solutions across CTV, digital out-of-home, retail media, social, and digital channels. Its offerings include campaign management, audience targeting, search and content monetization, and video advertising technologies.

Affle 3i is an India-based global technology company that provides AI-driven mobile and digital advertising solutions to help advertisers target consumers, optimize campaigns, and drive conversions across mobile, CTV, and other connected devices. The company primarily operates on a Cost Per Converted User (CPCU) business model.

Deal Details and Timeline:

After the transaction closes, Perion will become a wholly owned subsidiary of Affle while continuing to operate under the Perion brand.

The merger agreement also includes a 40-day “go-shop” period that ends December 11, 2026.

The deal is expected to be completed in early 2027.

Citibank is providing the debt financing to support the transaction.

Canaccord Genuity is advising Perion on the financial aspects of the deal, while Meitar Law Offices is providing legal advice. Similarly, LUMA Partners is advising Affle on the financial side, and Barnea Jaffa Lande & Co. is handling its legal matters.

Deal Metrics:

For more in-depth information regarding this merger and acquisition, please visit the Deal Metrics page here:

Deal Metrics for the acquisition of Perion (PERI) by Affle 3i Ltd.

The Deal Metrics page for each merger or acquisition includes:

• A spread history chart of the merger from announcement through eventual completion or failure.
• Every event as the merger progresses through the expiration of the HSR period, various regulatory approvals, shareholder votes, etc.
• News and SEC filings.
• A history of deal updates.
• And a whole lot more.

Disclaimer: Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.

Editor’s Note: Baranjot Kaur contributed to this article